Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 229 (RN7SKP229) is a human genomic locus classified as a noncoding RNA pseudogene, specifically a member of the large group of RN7SK-related pseudogenes. While the *functional* RN7SK gene encodes 7SK small nuclear RNA, an essential noncoding RNA component involved in the regulation of RNA Polymerase II transcription elongation, RN7SKP229 itself is not known to be transcribed or translated, and is assumed to lack biological activity. As with most pseudogenes, RN7SKP229 likely arose from duplication or retrotransposition events, and does not function as a therapeutic target[6][3]. Key context: - The *functional* RN7SK gene and its RNA product play a crucial role in transcription regulation, mediating control of P-TEFb and affecting processes including the cell cycle and disease, but this is distinct from pseudogenes such as RN7SKP229[1][2][5][7]. - Pseudogenes often share sequence similarity to their parent genes but lack protein-coding ability or function due to disabling mutations[3][6]. Summary of appropriateness: RN7SKP229 should not be used as a canonical therapeutic target in drug discovery or molecular biology. Any references to targeting "RN7SKP229" would be incorrect; the functional/non-pseudogene counterpart ("RN7SK small nuclear RNA") is the relevant molecule for functional studies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 229 (RN7SKP229).